Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
      1
23
4
5678
910111213
14
15
16
17
1819202122
23242526272829
30      
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 ยป More




| 1 |

 

 
  Tags
 
ADD medical costs flumazenil chronic pain substance use disorder meth cigarettes gabapentin ADHD sober PTSD Research Across America urine drug screen facebook opiates medical and behavioral costs methadone physician- patient relations ER binge drinking craving trauma reduction in craving opiod-based alcohol drinking hospitalizations marijuana prescriptions narcotic dependence issues reducing craving alcohol addict suboxone stratified depression contract behavioral health sugar opioid opioid antagonist vicodin drug overdose recovery health plan CIWA substance dependence costs OnTrak craving score stress behavioral health care services stimulants Harold Urschel vivitrol placebo buprenorphine codeine heroin fentanyl alcoholism diabetes muscle relaxant reduction in use substance dependence health insurance health insurance pain pills anxiety Health Care Utilization Catasys hospital predictive modeling communication depression screening prometa cocaine treatment Raymond Anton morphine opioid-drug interactions opioid overdose emergency room mental health pain medication behavioral health care high-utilizing over-the-counter substances SD health insurance Opioid Medications treatment data mining painkillers methamphetamine mental illness medical drinking alcohol treatment substance dependence drug addiction Journal of Psychopharmacology double-blind sobriety placebo-controlled randomized psychosocial Co Occurring Disorders opiod abuse methamphetamine dependence alcohol dependence relapse withdrawal cocaine care coaching addiction smoking UnitedHealthcare OxyContin SD members naloxone nicotine opioid abuse drug use addiction treatment pain killers behavioral healthcare post-traumatic stress disorder oxycodone behavioral healthcare services social network identification percocet Opioid Prescribing Opioid Treatment hydrocodone drug treatment overdose drug abuse primary care bipolar disorder recovery network relapse prevention health reform drug addicts
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414